U.S. Osteoporosis Market
U.S. Osteoporosis Market
RELEASE DATE
26-Jun-2008
26-Jun-2008
REGION
North America
North America
Research Code: N36B-01-00-00-00
SKU: HC02069-NA-MR_07479
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02069-NA-MR_07479
Description
This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bisphosphonates, selective estrogen receptor modulators, calcitonins, parathyroid hormones, and novel therapeutic approaches. Major market challenges, drivers, and restraints and identified and discussed.
Table of Contents
Executive Summary
- Introduction
Research Scope and Methodology
- Scope & Segmentation
- Research Methodology
Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Product Analysis
- Bisphosphonates
- Selective Estrogen Receptor Modulators
- Calcitonins
- Parathyroid Hormones
Pipeline Analysis
- Bisphosphonates
- Selective Estrogen Receptor Modulators
- Calcitonins
- Parathyroid Hormones
- Novel Therapeutic Approaches
Competitive Analysis
Forecasts and Trends
Market Share Analysis
Decision Support Databases
Popular Topics
This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bisphosphonates, selective estrogen receptor modulators, calcitonins, parathyroid hormones, and novel therapeutic approaches. Major market challenges, drivers, and restraints and identified and discussed.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N36B-01-00-00-00 |
Is Prebook | No |